Irinotecan liposome Intravenous and Mogamulizumab-kpkc
Determining the interaction of Irinotecan liposome Intravenous and Mogamulizumab-kpkc and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: irinotecan liposomal
Brand name: Onivyde
Synonyms: Irinotecan liposomal, Irinotecan (Liposomal)
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: Mogamulizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Irinotecan liposome Intravenous-Mogamulizumab-kpkc Intravenous
- Irinotecan liposome Intravenous-Molindone
- Irinotecan liposome Intravenous-Mometasone (Oral Inhalation)
- Irinotecan liposome Intravenous-Mometasone and Formoterol
- Irinotecan liposome Intravenous-Mometasone and formoterol Inhalation
- Irinotecan liposome Intravenous-Mometasone Cream
- Mogamulizumab-kpkc-Iron 100/C
- Mogamulizumab-kpkc-Iron 21/7
- Mogamulizumab-kpkc-Iron and Docusate
- Mogamulizumab-kpkc-Iron and Folic Acid
- Mogamulizumab-kpkc-Iron and Vitamin C
- Mogamulizumab-kpkc-Iron Chewable Tablets